Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Bafaloukos, D. & Gogas, H. The treatment of brain metastases in melanoma patients. Cancer Treat Rev. 30(6), 515–20 (2004).
2. Davies, M. A. et al. Prognostic factors for survival in melanoma patients with brain metastases. Cancer. 15;117(8), 1687–96, https://doi.org/10.1002/cncr.25634 . Epub 2010 Oct 19 (2011).
3. Carlino, M., Atkins, M. & Warneke, C. Differences between Australia (OZ) and the United States (US) in the patterns, prognosis, and treatment of melanoma CNS metastases: analysis from the PHAMOUS (prognostic heterogeneity in patients with advanced melanoma between OZ & the US) study. Pigment Cell Melanoma Res 23, 874–1004 (2010).
4. Amer, M. H., Al-Sarraf, M., Baker, L. H. & Vaitkevicius, V. K. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer. 42(2), 660–8 (1978).
5. de la Monte, S. M., Moore, G. W. & Hutchins, G. M. Patterned distribution of metastases from malignant melanoma in humans. Cancer Res. 43(7), 3427–33 (1983).
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献